Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1995Antimicrobial Agents and ChemotherapyOpen Access

Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis

View Full Paper
Ask AI
Bookmark
Share

Authors

CBClaudia M. BrandtGoethe University FrankfurtMRMark S. RouseMayo ClinicBTB M TallanMayo Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brandt et al. (1995) studied this question.

synapsesocial.com/papers/6a7e682090450c7e0f32f96dhttps://doi.org/10.1128/aac.39.8.1815
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis1990 · 34 citations
  2. 2In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficile1990 · 42 citations
  3. 3Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole1990 · 55 citations
  4. 4Selection of vancomycin- and teicoplanin resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection1990 · 53 citations
  5. 5Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus1994 · 16 citations